Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Donald Trump scores big win in South Carolina Republican primary
    • Global house prices rebound as economists predict turning point
    • Trump says he is a ‘dissident’ under siege from thugs in bleak speech
    • Malaysia’s prime minister decries ‘China-phobia’ among US and western allies
    • Trump pivots to race against Biden after crushing Haley in South Carolina
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
    Most Read
    • UK Conservatives battle to retain ‘true blue’ rural heartlands
    • Conservative party suspends Lee Anderson over Sadiq Khan comments
    • UK deputy PM declines to say if Lee Anderson comments over Sadiq Khan were racist
    • Birth rate drops to new low in England and Wales
    • ‘Macho’ all-male Rochdale by-election fuels political divisions over Gaza
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Jim Ratcliffe warns EU bureaucracy will drive away industry’s investments
    • Warren Buffett admits Berkshire Hathaway’s days of ‘eye-popping’ gains are over
    • Indonesia to wipe out global nickel rivals, warns French miner Eramet chief
    • Goldman insider-trading conviction shows UK watchdog sharpening its teeth
    • European football needs innovation and drama, says Real Madrid and FC Barcelona investor
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Indonesia to wipe out global nickel rivals, warns French miner Eramet chief
    • How Germany’s steelmakers plan to go green
    • Goldman insider-trading conviction shows UK watchdog sharpening its teeth
    • $100mn in crypto payments traced to Myanmar-based ‘scammers’
    • Public service pensions are the elephant in the room
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why is Nikki Haley still running?
    • Western timidity has only emboldened Putin
    • The global trade system is in desperate need of an overhaul
    • The forgotten war
    • The metropolitan elite has ignored farmers for too long
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Fewer trips, fewer planes: business travellers rethink old habits
    • The menace of the overblown job title
    • ‘Every person slips at some point’: how businesses are managing the four-day week
    • ‘The one thing I’ve always had is deal flow’: RedBird’s Gerry Cardinale
    • Good news. We’ve got the contract for the worst idea in the world
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Zone of Interest director Jonathan Glazer: ‘I’m suspicious of people making Holocaust films’
    • Six cool California hotels to book now
    • Across ‘Saxon Switzerland’ in the footsteps of Caspar David Friedrich
    • Can a friendship app cure loneliness?
    • ‘They are among us’: Russia’s terrifyingly effective poisoning operation
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Disease control and prevention

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Monday, 26 February, 2024
    Biotech
    UK vaccine start-up raises £14mn to develop AI-boosted adaptable vaccines

    Baseimmune aims to predict future pathogen mutations to create jabs that will be effective for longer

    new
    Baseimmune co-founders, from left, Ariane Gomes, Phillip Kemlo and Josh Blight
  • Sunday, 25 February, 2024
    Brazil
    Brazil rolls out dengue vaccines as cases rise sharply

    Infections quadruple from last year after warnings that warming temperatures will increase cases

    People wait outside a provisional military field hospital treating those suffering from dengue, in the Ceilandia neighborhood of Brasilia, Brazil
  • Thursday, 22 February, 2024
    UK risks missing out on ‘golden age’ of drug discovery, cancer charity warns

    Head of Cancer Research UK calls for more investment and points to heavy reliance on philanthropic funding

    Michelle Mitchell, CRUK chief executive,
  • Wednesday, 21 February, 2024
    Coronavirus
    Anti-viral protein found to be important long Covid indicator

    Discovery boosts efforts to develop ‘biomarkers’ for debilitating condition and enable treatments

    A worker holds a blood sample in a test tube
  • Monday, 19 February, 2024
    AstraZeneca PLC
    AstraZeneca unveils successes in treatment of lung cancer

    Best-selling Tagrisso drug slows progression of most common form of the disease at an early stage

    AstraZeneca’s logo outside its offices in Hamburg, Germany
  • Monday, 19 February, 2024
    Life and Art from FT Weekend podcast18 min listen
    How technology is changing our bodies

    Journalist Manoush Zomorodi explains her recent experiment in attempting to get her listeners to move more – and why it’s so hard to break our pattern of sitting

  • Thursday, 15 February, 2024
    Antibiotic resistance
    ‘Potent’ antibiotic drug boosts fight against superbugs

    New molecule proves effective in animals against several drug-resistant bacteria

    A coloured scanning electron micrograph (SEM) of methicillin-resistant Staphylococcus aureus (MRSA) bacteria
  • Thursday, 15 February, 2024
    News in-depthCoronavirus treatment
    Scientists grapple with long Covid puzzle as millions fall sick

    Fears condition’s range of symptoms and link to chronic diseases will have lasting impact on health systems

    Montage of virus and X-ray view of upper human body
  • Monday, 12 February, 2024
    Dementia
    Blood protein test offers ‘reliable’ Alzheimer’s warning 15 years early

    Large study further boosts fast-evolving efforts to predict and prevent neurogenerative diseases

    A neurologist holds an MRI scan of a human head
  • Thursday, 8 February, 2024
    War in Ukraine
    UK to scrap Covid intensive care kit despite offer to send to Ukraine

    Machines lack a CE certification showing they comply with EU performance and safety directives

    A patient in a hospital bed wears a CPAP device
  • Tuesday, 6 February, 2024
    Israel-Hamas war
    Gazans search in vain for medicines

    Cancer, diabetes and heart disease patients among those facing chronic shortage of treatments

    Palestinians wait to buy medicine as pharmacies are mostly empty because of the drug supply shortage
  • Tuesday, 6 February, 2024
    LexPharmaceuticals sector
    Big Pharma still needs trial success to overcome looming patent panic Premium content

    Pharma companies, while talking up pipelines, are turning to deals to boost their growth outlook

    A Bristol Myers Squibb sign on a facility in Cambridge, Massachusetts, US
  • Sunday, 4 February, 2024
    Novo Nordisk AS
    Novo Nordisk ‘surprised’ by high European demand for weight-loss drugs

    Chief executive says customers very willing to pay for Wegovy from their own pockets

    Injection pens and boxes of Novo Nordisk’s weight-loss drug Wegovy
  • Thursday, 1 February, 2024
    Manica Balasegaram
    Antibiotic resistance is the greatest threat to cancer patients

    Investing in new oncology drugs without building up an effective arsenal against infections is a false economy

    A nurse hangs a bag of medicine
  • Wednesday, 31 January, 2024
    Medical science
    Scientists use Crispr gene editing to treat hereditary disorder

    Huge reduction in bouts of angioedema increases prospect that technique can combat a range of diseases

    Confocal Fluorescence Microscopy of Crispr- generated knockout cells
  • Monday, 29 January, 2024
    Dementia
    Alzheimer’s was passed between humans in now-banned procedure, study finds

    Cases connected to growth hormone extracted from cadavers show disease’s parallels with CJD brain disorder

    Someone holding up a brain scan
  • Monday, 29 January, 2024
    GSK PLC
    GSK’s new RSV jab set to achieve blockbuster status

    Strong uptake of UK pharma group’s vaccine has helped to ease fears of a patent cliff

    The GSK company logo
  • Sunday, 28 January, 2024
    The FT ViewThe editorial board
    The worrying return of a nasty virus

    Better awareness and access are needed to rebuild measles vaccination rates

    A toddler in her mothers arms while she is inoculated in the arm
  • Sunday, 28 January, 2024
    GSK PLC
    GSK refuses to join Ireland’s mother and baby home compensation scheme

    Forerunners of pharma company tested vaccines at notorious institutions for decades

    Francis Timmons looks left out of his lounge window while sitting on a sofa. He holds a framed photograph of his mother
  • Thursday, 25 January, 2024
    Drugs research
    Eli Lilly’s weight-loss drug set for UK launch ‘within weeks’

    Mounjaro has achieved 22.5 per cent loss of body weight in trials

    A pharmacist displays a box of Mounjaro
  • Tuesday, 23 January, 2024
    Pandemic resilience effort must match Covid R&D funding, says health chief

    Chair of 100 Days Mission warns of huge economic cost if world cannot act swiftly to tackle pathogens

    Mona Nemer
  • Monday, 22 January, 2024
    Medical science
    Blood test boosts hopes of early Alzheimer’s diagnosis

    Swedish trial finds ‘high accuracy’ in identifying protein associated with toxic build-up in the brain

    A finger points at a brain scan
  • Monday, 22 January, 2024
    First mass malaria vaccination campaign begins in Africa

    Shots will be given to children in Cameroon as part of rollout of up to 30mn jabs across continent

    Olga Victorino, 25, holds her 2-year-old son who had just tested positive for malaria
  • Thursday, 18 January, 2024
    Coronavirus
    Blood protein changes offer clue to solving long Covid riddle

    Research boosts efforts to diagnose and devise treatments for debilitating condition

    A close-up of a person looking at a Covid-19 test
  • Thursday, 18 January, 2024
    Visual story
    Can AI help us speak to animals?

    Scientists are eavesdropping on animal conversations. Will generative AI enable us to talk back?

Previous page You are on page 1 Next page

Join us at an FT Live event

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
Strategies to Address Obesity in America’s Workforce
Tackling the business and health impacts
Wednesday, 28 FebruaryNew York
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Explore all events

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board NetworkBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • UK
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In